Another in situ anti-tumor vaccination was a multifunctional nanocomplex based on calcium crosslinked polyaspartic acid conjugated to both TLR7/8 agonist IMDQ and the photosensitizer IR780. This evidence concerns the gene TLR7 and neoplasm.